Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Houston, TX, Sept. 14, 2017 -- Heart patients, family members, caregivers and medical professionals from across the country are expected to participate in the Mended Little Hearts CHD Symposium September 22-23, 2017 in Houston, Texas. The two-day event will be held at Texas Children’s Hospital and includes an ‘Out of this World’ reception, a tour of Texas Children’s Hospital Heart Center and entrance to the Houston Astros game Saturday evening.
|
||||||
The conference is open to anyone affected by congenital heart disease and will feature multiple speakers, including panels on supporting teens and families during their transition to adult CHD care, innovations in CHD treatment, collaborative innovations that improve lives, caring for the needs of the child and family, and more.
"I am truly excited that we are bringing our CHD Symposium to Houston,” said Donnette Smith, President of Mended Hearts and Mended Little Hearts. “Not only will participants hear about the latest innovations in CHD research and treatment, but they’ll learn how collaboration between medical staff, patients and caregivers can help improve the lives of those affected by CHD. They’ll also have the unique opportunity to network with other patients and families who have gone through what they’ve experienced.”
To register for the MLH CHD Symposium, please go to:
https://events.r20.constantcontact.com/register/eventReg?oeidk=a07eee1g3j58e69d9a0&oseq=&c=&ch=
Mended Little Hearts gratefully acknowledges the support of our Symposium sponsors: Edwards Lifesciences, Abbott, Prolacta, Syncardia, and Medtronic.
About Mended Little Hearts
Mended Little Hearts plays a significant role in the lives of families with children diagnosed with congenital heart defects. Through its local support group meetings, health education to communities, hospital support programs, disease awareness activities, and advocacy on issues that affect our families, Mended Little Hearts provides hope, help and healing so families can be families and kids can be kids. Mended Little Hearts is a program of The Mended Hearts Inc., a non-profit, volunteer-based organization providing hope, help and healing to heart patients and their families since 1951.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/67752cc8-cf16-42d3-b3cc-f4d6ec61163a
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/edf18634-9cba-4314-903b-5c85472e03a7
Mandy Sandkuhler Mended Little Hearts 4698883400 [email protected]
